BioNTech SE (BNTX) Intangibles (2018 - 2025)
BioNTech SE (BNTX) reported Intangibles of $1.9 billion for Q4 2025, up 121.34% on a YoY basis from $844.6 million in Q4 2024, and up 15.06% sequentially from $1.6 billion in Q3 2025.
BioNTech SE (BNTX) Intangibles (2018 - 2025) Analysis & Trends
BioNTech SE (BNTX) has 8 years of Intangibles data on file, last reported at $1.9 billion in Q4 2025.
- For the quarter ending Q4 2025, Intangibles rose 121.34% year-over-year to $1.9 billion; the trailing twelve-month figure through Dec 2025 stood at $1.9 billion (up 121.34% YoY), and the FY2025 full-year result was $1.8 billion, up 114.83% from the prior year.
- Intangibles grew to $1.9 billion in Q4 2025, from $1.6 billion in the prior quarter.
- In the past five years, Intangibles ranged from a high of $1.9 billion in Q4 2025 to a low of $66.1 million in Q4 2021.
- A 5-year average of $726.2 million and a median of $635.2 million in 2023 frame the typical range for Intangibles.
- Across the five-year window, Intangibles tumbled 73.2% in 2021 and jumped 281.46% in 2023, its largest moves.
- Tracing BNTX's Intangibles over 5 years: stood at $66.1 million in 2021, then jumped by 243.01% to $226.8 million in 2022, then jumped by 281.46% to $865.2 million in 2023, then dropped by 2.37% to $844.6 million in 2024, then soared by 121.34% to $1.9 billion in 2025.
- Business Quant data shows BNTX's Intangibles at $1.9 billion in Q4 2025, $1.6 billion in Q3 2025, and $1.7 billion in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 11,640.44 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 61.68 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.92 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 55.80 Mn |
| 10 | BioNTech SE | 22.13 Bn | 22.13 Bn | 668.28 Mn | 1.87 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.87 Bn |
| Sep 30, 2025 | 1.62 Bn |
| Jun 30, 2025 | 1.68 Bn |
| Mar 31, 2025 | 1.59 Bn |
| Dec 31, 2024 | 844.62 Mn |
| Sep 30, 2024 | 959.73 Mn |
| Jun 30, 2024 | 928.60 Mn |
| Mar 31, 2024 | 892.66 Mn |
| Dec 31, 2023 | 865.16 Mn |
| Sep 30, 2023 | 724.46 Mn |
| Jun 30, 2023 | 545.99 Mn |
| Mar 31, 2023 | 406.37 Mn |
| Dec 31, 2022 | 226.80 Mn |
| Sep 30, 2022 | 228.07 Mn |
| Jun 30, 2022 | 236.25 Mn |
| Mar 31, 2022 | 242.42 Mn |
| Dec 31, 2021 | 66.12 Mn |
| Sep 30, 2021 | 192.11 Mn |
| Jun 30, 2021 | 197.62 Mn |
| Mar 31, 2021 | 199.27 Mn |